CG Oncology Inc (CGON) Stock Price, Quote, News & History

CGONNASDAQ
$74.67
0.340.46%
At close: Sep 4, 5:00 PM EST
$74.67
N/A
After Hours: Sep 4, 4:00 PM EST

CG Oncology (CGON) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-178.47M
Investing Cash Flow (TTM)
-364.88M
Financing Cash Flow (TTM)
548.36M
Free Cash Flow (TTM)
-179.34M
Capital Expenditure (TTM)
-876.00K
Net Change in Cash (TTM)
5.01M

Analyst Trends and Forecast

3
Apr
6
May
3
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$5.60B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
983.24
PB Ratio (TTM)
6.40
Earnings Yield % (TTM)
-3.62%
Earnings Yield % (FWD)
-3.77%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$11.61

Company Debt

Total Debt
$3.00M
LT Debt
$3.00M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$19.64M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$73.02
Close
$74.67
Volume / Avg.
282.52K / 961.41K
Day Range
$72.87 - $74.88
52 Wk Range
26.92 - 80.97
Market Cap
$6.62B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
49
Short Interest
12.92%
Days to Cover
14.85

About

Sector
Health Care
Industry
Biotechnology
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorep...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy CG Oncology (CGON) stock?

A

You can purchase shares of CG Oncology (NASDAQ:CGON) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for CG Oncology (CGON) stock?

A

CG Oncology has a consensus price target of $71.94.

Q

What is the current price for CG Oncology (CGON)?

A

The stock price for CG Oncology (NASDAQ: CGON) is $74.67 last updated September 4, 2026 at 4:00 PM EDT.

Q

Does CG Oncology (CGON) pay a dividend?

A

There are no upcoming dividends for CG Oncology.

Q

When is CG Oncology (NASDAQ:CGON) reporting earnings?

A

CG Oncology does not have any upcoming earnings scheduled.

Q

Is CG Oncology (CGON) going to split?

A

There is no upcoming split for CG Oncology.

Q

What sector and industry does CG Oncology (CGON) operate in?

A

CG Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.